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Occupational asbestos exposure has been endemic in Portsmouth. A retrospective case
note analysis of 50 patients who underwent thoracoscopy over a 2-year period from
January 2003 was undertaken. Biopsies were taken in 47 cases, 31 of which showed
malignant mesothelioma. Thirty seven percent of those without a history of direct
exposure to asbestos had mesothelioma, implying that even in the absence of an exposure
history a low threshold for investigation should be adopted for the local population. There
was no mortality or significant morbidity associated with the procedure. Medical
thoracoscopy is safe and effective in the diagnosis of benign and malignant pleural
disease particularly in this high risk population.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Thoracoscopy was introduced by Jacobaeus in 1910 to
investigate the cause of exudative pleural effusions,
particularly those secondary to TB. There remains debate
as to whether this procedure is in the domain of the
physician or the surgeon.1–3 Surgical thoracoscopy requires
general anaesthesia with selective endobronchial intubation
and typically three points of entry through the chest wall.Elsevier Ltd. All rights reserved.
2 303626.
tors.org.uk (S.V. Fletcher).
horacic Medicine, The Royal
BH7 7DW, UK.Medical thoracoscopy requires local anaesthesia with pre-
medication and usually one or two points of entry.
Medical thoracoscopy has both a diagnostic and a
therapeutic role.4 It provides a means of diagnosis for
pleural exudates of unknown aetiology. It has a high
sensitivity in malignant and tuberculous effusions5 and
allows fast and more definite histological diagnosis via
biopsy under direct vision.
Therapeutic manoeuvres include talc insufflation for
pleurodesis; this provides the best conservative method of
pleurodesis in malignant and recurrent benign effusions,6
which is enhanced when there is complete drainage of the
pleural fluid and apposition of the parietal and visceral
pleurae.
Thoracoscopy has a particularly important role in both
diagnosis and management of malignant mesothelioma.7
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has a sensitivity of only 32%.8 Faced with an undiagnosed
pleural effusion and a high index of suspicion of mesothe-
lioma, recurrent pleural aspiration is best avoided as it
carries risk of needle track spread of the disease. Thoraco-
scopy not only allows the removal of the pleural fluid and
biopsies under direct vision, but also pleurodesis at the same
time.
The Queen Alexandra Hospital in Portsmouth is a busy
District General hospital. Due to the close proximity of the
Portsmouth Dockyards, the local population has a high
prevalence of asbestos-related respiratory disease including
malignant mesothelioma.
In selected patients where no contraindications are
observed, medical thoracoscopy seems to be a safe
uncomplicated technique with high diagnostic accuracy in
the hands of the physician.9 The aim of this study was to
assess the validity of this statement in this unit serving
the local population where asbestos exposure has been
endemic.Materials and methods
Patients
Fifty patients who had undergone medical thoracoscopy
between 1 January 2003 and 31 December 2005, whatever
the indication, were selected at random. Only 50 were
selected due to the constraints of the study. A total of 79
thoracoscopies took place in this period, performed/
supervised by three different operators. None of the
patients underwent the procedure more than once.Table 1 Characteristics of the study population.
Characteristics No. (%) (n ¼ 50)
Male gender 43 (86)
Female gender 7 (14)
History of smoking 45 (90)
Asbestos exposure 29 (58)
Table 2 Initial diagnoses based on thoracocentesis and
cytology.Pre-thoracoscopy assessment
In every case the smoking history, exposure to asbestos,
occupation, relevant past medical history—including perso-
nal history of cancer, was reviewed directly from the case
notes. Those who were ‘never smokers’ were deemed to
have no smoking history. Asbestos exposure was defined as
documentation of recollection by the patient of direct
exposure 7 an occupation of high risk (e.g. pipe lagging,
working in the Dockyards, Naval stokers).
Thoracocentesis was performed in all cases, the results
were noted which included the biochemistry of the pleural
fluid, results from microscopy, culture and sensitivity and
cytology. These results were obtained via ‘apex’ the hospital
computer system that stores all laboratory investigation
results. Histology results were gained by the same means.Cytological diagnosis No. (%) (n ¼ 50)
Inflammatory cells 11 (22)
Mesothelial cells 16 (32)
Reactive mesothelial cells 12 (24)
Atypical and reactive cells 1 (2)
Atypical cells 6 (12)
Suggestive of epithelial mesothelioma 2 (4)
Suggestive of mesothelioma 1 (2)
No cytology sent 1 (2)Thoracoscopy procedure
Thoracoscopy was performed as described in ‘Thoracoscopy
for physicians’10 under local anaesthesia. Following removal
of the fluid a rigid thoracoscope was inserted and the pleural
cavity inspected. Biopsies were taken under direct visualisa-
tion in all suspect areas of the parietal pleura, but never of
the visceral pleura. Where indicated, talc poudrage was
applied in the pleural space. An intercostal chest drain wasinserted before wound closure to allow for evacuation of
fluid and air.
The ECG, blood pressure and oximetry were monitored
throughout the procedure and continued for the next 6 h
post-procedure.
Post-thoracoscopy care
The chest drain was not clamped and high volume low
pressure suction was applied. In the absence of excessive
fluid drainage (4200ml/day), the drain was removed 72 h
after insertion.
Complications were recorded by a review of the individual
case notes.
Results
The characteristics of the patients are shown in Table 1. The
mean age of the study population at the time of the
procedure was 72 (range 49–84).
All patients underwent thoracocentesis prior to thoraco-
scopy. In 48 cases pleural fluid samples were sent for
biochemical analysis, all were an exudate (mean protein 49
and mean LDH 1401). In the two cases where this test was
not performed the final diagnosis was mesothelioma. In all
50 cases pleural fluid was sent for microscopy, culture and
sensitivities, all were sterile. The cytology results are
detailed in Table 2.
None of the patients underwent closed pleural biopsy
prior to thoracoscopy. The rationale behind this manage-
ment is explored in the Discussion.
The histological results from the diagnostic thoracoscopy
in each patient are presented in Table 3.
No biopsies were taken in three cases, firstly in a 49-year-
old woman with known metastatic carcinoma of the breast,
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procedure abandoned. In the second case, no abnormality of
the pleura was noted and clinically the effusion was
suspected to be parapneumonic. In the third case, extensive
adhesions made continuation of the procedure hazardous,
malignant mesothelioma was diagnosed following thoracot-
omy under general anaesthesia. Image guided cutting
needle biopsy could have been considered in this case post
to thoracoscopy.
One of the cases suspected of mesothelioma was
confirmed when the pleural biopsies and subsequent skin
biopsies were compared. Immunostaining was unable to
firmly make the diagnosis of mesothelioma in the remaining
two cases.
The population undergoing thoracoscopy were selected
not to include those with positive cytology from simple
aspiration. 3/31 cases of mesothelioma had positive
cytology prior to the procedure (Table 4).
If positive cytology is defined as being highly suggestive of
mesothelioma as oppose to atypical or reactive mesothelial
cells, a sensitivity of 3/31 and a specificity of 100% fromTable 3 Results of diagnostic thoracoscopy.
Diagnoses No. (%) (n ¼ 50)
Benign
Rheumatoid 1 (2)
Pleural fibrosis 2 (4)
Non-specific inflammation 4 (8)
Malignant
Mesothelioma—type not given 12 (24)
Fibrous mesothelioma 1 (2)
Biphasic mesothelioma 3 (6)
Sarcomatoid mesothelioma 3 (6)
Spindle cell mesothelioma 1 (2)
Epitheliod mesothelioma 11 (22)
Suspected mesothelioma 3 (3)
Adenocarcinoma of the lung 2 (4)
Neuroendocrine carcinoma of the lung 1 (2)
Carcinoma of the pancreas 2 (4)
Carcinoma of the prostate 1 (2)
No biopsies taken 3 (6)
Table 4 Cytology results in the presence or absence of mesoth
Cytology
Inflammatory cells
Mesothelial cells
Reactive mesothelial cells
Atypical and reactive cells
Atypical cells
Suggestive of epithelial mesothelioma
Suggestive of mesothelioma
No cytology sentpleural fluid cytology is obtained from this data. In all three
cases where the histology was suggestive but not diagnostic
of mesothelioma, cytology demonstrated either reactive or
inflammatory cells.
For the other malignancies involving the pleura the
results from cytology were non-diagnostic which was the
indication for thoracoscopy.
The results from the pleural biopsies were compared with
the history of asbestos exposure. As expected, where the
diagnosis is malignant mesothelioma, there is often a good
history of asbestos exposure (Fig. 1).
There were a significant number of cases with no history
of asbestos exposure where subsequently either a diagnosis
mesothelioma or pleural fibrosis was made (Fig. 2).
The complications of thoracoscopy are shown in Table 5.
There were no deaths directly attributable to the proce-
dure, however, one 81-year-old gentleman died 3 days
post-thoracoscopy from renal failure associated with his
metastatic prostate cancer, confirmed on histology from
the procedure. Of the 3 cases of infection around the
wound site, none resulted in severe sepsis or empyema,elioma.
Non-mesothelioma Mesothelioma
No. (%) (n ¼ 19) No. (%) (n ¼ 31)
8 3
5 11
3 9
0 1
3 3
0 2
0 1
0 1
Mesothelioma
Chronic inflammation
Benign pleural fibrosis
n=23 (80%)
n=3 (11%)
n=1 (3%)
Lung carcinoma
n=1 (3%)
Neuroendocrine carcinoma of
the lung
n=1 (3%)
Figure 1 Histological result with a history of asbestos
exposure.
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Rheumatoid
n=1 (5%)
Suspected mesothelioma
n=3 (14%)
Mesothelioma
n=8 (37%)Adenocarcinoma of the lung
n=1 (5%)
Pancreatic carcinoma
n=2 (10%)
Prostatic carcinoma
n=1 (5%)
n=1 (5%)
n=1 (5%)
No biopsies taken
n=3 (14%)
Chronic inflammation
Pleural fibrosis
Figure 2 Histological diagnosis with no history of exposure to
asbestos.
Table 5 Complications of medical thoracoscopy.
Complication No.
Subcutaneous emphysema 2
Drain site infection 3
Hypotension during procedure 1
Drain dislodged post-procedure 1
Confusion due to opiods 1
Air leak requiring surgery 1
S.V. Fletcher, R.J. Clark1024Staphylococcus aureus was implicated in one case and
Staphylococcus epidermidis in another. Nine of the 50
patients experienced some form of complication (18%).
There were five cases of failure of lung re-expansion or
‘trapped lung’ all of which occurred in the context of
mesothelioma. One patient had a persistent air leak post-
thoracoscopy that required VATS. There was no documented
trauma to the visceral pleura noted in the thoracoscopy
report, but this remains a possibility; the air leak may have
resulted from the shearing forces applied to the visceral
pleura upon re-expansion.Discussion
The role of thoracoscopy in the diagnosis of pleural effusions
of unknown aetiology and particularly in the context of
mesothelioma is established.6 What was strikingly apparent
from the above results was the prevalence of pleural
malignancy within the population undergoing thoracoscopy.
This is at least partially attributable to the prevalence of
asbestos exposure within the local population, but also due
to the selection of those undergoing the procedure.
All of the patients, prior to thoracoscopy, had pleural fluid
sent for microbiological studies, all of which were known to
be negative before the procedure was undertaken. It is
routine practice in this unit for all cases of suspected
thoracic malignancy to have a staging CT of the thorax 7 a
bronchoscopy prior to discussion at a multi-disciplinary team
(MDT) meeting. Any cytology results from a pleural aspirate
are also discussed. Only those cases not amenable tobronchoscopy or CT/US-guided biopsy in the context of a
pleural effusion and non-diagnostic cytology are put forward
for thoracoscopy. Given this selection process, which aims to
exclude pleural infections and often provides alternate
means for the diagnosis of lung cancer, it is hardly surprising
that the large majority cases undergoing medical thoraco-
scopy result in the diagnosis of mesothelioma. This retro-
spective study shows a selection bias toward including
patients with known malignancy or a high pre-test prob-
ability of malignancy, particularly mesothelioma.
In all 29/50 of the patients undergoing thoracoscopy had
documented asbestos exposure, so increasing the pre-test
probability of pleural malignancy. Mesothelioma occurred in
the context of asbestos exposure which is to be expected,
however it was the diagnosis in 37% of those without
asbestos exposure. This is probably a reflection of the strict
criteria for asbestos exposure used in this study, the
characteristics of the local population and selection bias
outlined above. Even given these areas of bias, in this
particular population there should be a low threshold of
clinical suspicion of pleural malignancy in the right clinical
setting even in the absence of a history of asbestos
exposure.
In this study cytological evaluation was found to be of
limited use, probably due in part to the selection bias, the
majority of the cases had non-dignostic cytology, hence the
need to proceed to thoracoscopy, but also as cytology is
known to be of limited diagnostic use in the context of
mesothelioma.11
Closed needle biopsies prior to thoracoscopy are not
undertaken routinely in this unit. In a population where the
prevalence of mesothelioma and clinical suspicion is
relatively high, repeatedly traversing the pleural and
thoracic wall could pre-dispose to seeding of tumour. This
risk outweighs the potential diagnostic benefit of a closed
needle biopsy. In a large retrospective study only 7% of
patients with a malignant effusion had a positive closed
needle biopsy when the fluid cytology was negative.11
Thoracoscopy is far superior to cytology alone for the
diagnosis of pleural malignancy with a sensitivity reported as
91%, specificity of 100% and a negative predictive value of
93%.12
In 10% of the patients from this study there was failure of
lung expansion following drainage of the pleural effusion
and talc pleurodesis; all had malignant mesothelioma. In
these cases encasement of the lung by tumour prevented
reexpansion. There were no complications directly attribu-
table to pleurodesis. The complication rate for thoracoscopy
was low, with no mortality or significant morbidity. Other
larger studies have found the mortality rate to be less than
1%.13
Who should perform thoracoscopy remains an area of
debate. This study has demonstrated that in a select group
of patients, diagnostic pleural biopsy with talc pleurodesis is
achieved with high diagnostic accuracy and a high degree of
safety.
It could be argued given the poor prognosis of those with
pleural malignancies; there is little need to pursue the
diagnosis until therapeutic options have been developed.
Making the diagnosis gives prognostic information to the
patient, may have financial implications and in this high risk
population making a diagnosis of benign pleural disease is
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cohort of patients are identified who could be eligible for
therapeutic trials. Thoracoscopy via the use of pleurodesis
has an established role in symptom management.
Conclusion
In this region of the county where occupational asbestos
exposure is endemic, medical thoracoscopy is safe and
effective in the diagnosis of benign and malignant pleural
disease.
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